Core First Bank & Trust Viatris Inc Transaction History

Core First Bank & Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $772 - $1,029	-84 Reduced 36.21%	148 $1,000
Q4 2022 Feb 15, 2023	BUY	$8.72 - $11.56 $732 - $971	84 Added 56.76%	232 $2,000
Q3 2022 Nov 16, 2022	SELL	$8.48 - $11.13 $814 - $1,068	-96 Reduced 39.34%	148 $1,000
Q2 2022 Aug 16, 2022	BUY	$9.95 - $12.27 $467 - $576	47 Added 23.86%	244 $3,000
Q2 2021 Aug 17, 2021	SELL	$12.97 - $16.15 $75,498 - $94,009	-5,821 Reduced 96.73%	197 $3,000
Q1 2021 May 18, 2021	SELL	$13.59 - $18.54 $3,764 - $5,135	-277 Reduced 4.4%	6,018 $84,000
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $90,018 - $117,968	6,295 New	6,295 $118,000

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Core First Bank & Trust with notifications on news.